C.?The Association for the Accreditation of Human Research Protection Programs Inc. today announced that it has awarded accreditation to four additional organizations, including one more in Korea.
The Association for the Accreditation of Human Research Protection Programs Inc
. today announced that it has awarded accreditation to four additional organizations, including one more in Korea. The newly accredited organizations are:
The accreditations are the latest example of AAHRPP’s continued growth throughout the research enterprise. They also reflect AAHRPP’s steady progress in achieving the goal of one standard worldwide for protecting research participants and advancing high-quality research.
“These accreditations underscore that AAHRPP’s standards apply equally well to organizations across the research spectrum,” said Marjorie A. Speers, Ph.D., AAHRPP president and CEO. “AAHRPP accreditation is widely regarded as the mark of a quality human research protection program worldwide.”
AAHRPP accreditation is available to U.S. and international organizations that conduct biomedical, behavioral or social sciences research involving human participants. To date, AAHRPP has accredited organizations in 46 states, Canada, China, India, Korea, Mexico, Singapore and Taiwan.
Since its founding in 2001, AAHRPP has been instrumental in persuading research organizations to focus on quality improvement and routinely assess their performance. As a result, today’s AAHRPP-accredited HRPPs can point to measurable improvements in advancing research, protecting participants and building public trust.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access